NIH-funded research R01 grant

Vitamin D, gut bacteria and dementia risk in older adults with HIV

Official title: Vitamin D and Gut Microbiota and Dementia Risk in Older Adults with Chronic HIV infection and Demographically Matched Community Controls

Funded at Henry Ford Health + Michigan State University Health Sciences · NIH-11517874 · Data updated 2026-11-12

This work will look at whether low vitamin D and changes in gut bacteria are linked to higher dementia risk in older adults living with chronic HIV and similar community members.

More Dementia research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionHenry Ford Health + Michigan State University Health Sciences
NIH-funded
Lab location1 site (East Lansing, United States)
Project startJuly 15, 2024
Project endApril 30, 2029
Funding year2026
Award (this year)$281,093
NIH project number3R01AG087191-03S1
Project IDNIH-11517874 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are older adults (typically 65+) living with chronic HIV on antiretroviral therapy and demographically matched community controls who can provide blood and stool samples and complete cognitive testing.

Less likely to help

People younger than the study age range, those without chronic HIV who are not part of the control group, or individuals with advanced dementia are unlikely to receive direct benefit from participating.

What this research studies

If you join, researchers will compare vitamin D levels and the mix of bacteria in your gut with how memory and thinking change over time in older adults with chronic HIV and demographically matched community members. You would provide blood and stool samples, complete brief cognitive tests, and share health, medication, and nutrition information during clinic visits. The team will follow participants for several years to see which patterns predict new or worsening dementia-related symptoms. The goal is to find simple, modifiable targets such as correcting vitamin D deficiency or shifting gut bacteria to lower dementia risk in this aging population.

Why it matters

Potential benefit: If successful, this work could point to vitamin D correction or microbiome-based approaches that help prevent or delay dementia in older adults with HIV.

How similar studies have gone: Some prior research links low vitamin D or gut microbiome changes to worse cognition, but studies specifically in older adults with HIV are limited and findings are mixed.

Where this research is happening

  • Henry Ford Health + Michigan State University Health Sciences
    East Lansing, United States
    Active

Researchers

  • Principal investigator: Ezeamama, Amara E — Henry Ford Health + Michigan State University Health Sciences
  • Study coordinator: Ezeamama, Amara E

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.